De‐Wei Wu - Concepedia

Author

De‐Wei Wu

Taipei Medical University

Also Known As

De-Wei Wu, De-wei Wu, Dewei Wu, De‐Wei Wu

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Taipei Medical University Chung Shan Medical University Chung Shan Medical University Hospital Taichung Veterans General Hospital China Medical University

About

De‐Wei Wu is an author at Taipei Medical University specializing in medicine, tumor biology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	368
2	Cell Biology	8	8	243
3	Health Sciences	2	2	40
4	Public Health	1	1	27
5	Diabetes	1	1	12

De‐Wei Wu

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Paxillin Predicts Survival and Relapse in Non–Small Cell Lung Cancer by MicroRNA-218 Targeting De‐Wei Wu, Ya‐Wen Cheng, John Wang, Cancer Research	2010	128
Reduced p21WAF1/CIP1 via Alteration of p53-DDX3 Pathway Is Associated with Poor Relapse-Free Survival in Early-Stage Human Papillomavirus–Associated Lung Cancer De‐Wei Wu, Wen-Shan Liu, John Wang, Clinical Cancer Research	2011	95
Mitochondrial CMPK2 mediates immunomodulatory and antiviral activities through IFN-dependent and IFN-independent pathways Jenn‐Haung Lai, De‐Wei Wu, Chien‐Hsiang Wu, iScience	2021	62
Paxillin promotes tumor progression and predicts survival and relapse in oral cavity squamous cell carcinoma by microRNA-218 targeting De‐Wei Wu, Chun-Yi Chuang, Wea-Long Lin, Carcinogenesis ImmunologyTumor ProgressionPathologyCancer BiologyTumor Biology	2014	57
Loss of TIMP-3 Promotes Tumor Invasion via Elevated IL-6 Production and Predicts Poor Survival and Relapse in HPV-Infected Non–Small Cell Lung Cancer De‐Wei Wu, Lung‐Hung Tsai, Po-Ming Chen, American Journal Of Pathology Cancer ImmunosurveillancePredicts Poor SurvivalImmunologyTumor ImmunityPathology	2012	55
MicroRNA-21 promotes tumour malignancy via increased nuclear translocation of β-catenin and predicts poor outcome in APC-mutated but not in APC-wild-type colorectal cancer Po-Lin Lin, De‐Wei Wu, Chi-Chou Huang, Carcinogenesis	2014	54
Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2 Min‐Che Tung, Po-Lin Lin, Ya‐Wen Cheng, Oncotarget	2016	53
PD-L1 confers resistance to EGFR mutation-independent tyrosine kinase inhibitors in non-small cell lung cancer via upregulation of YAP1 expression Jai-Nien Tung, Po-Lin Lin, Yao-Chen Wang, Oncotarget	2017	49
The YAP1/SIX2 axis is required for DDX3-mediated tumor aggressiveness and cetuximab resistance in <i>KRAS</i>-wild-type colorectal cancer De‐Wei Wu, Po-Lin Lin, Lee Wang, Theranostics	2017	48
DDX3 enhances oncogenic KRAS-induced tumor invasion in colorectal cancer via the β-catenin/ZEB1 axis De‐Wei Wu, Po‐Lin Lin, Ya‐Wen Cheng, Oncotarget	2016	45

Page 1